20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.28.2023
The Director-General of the World Health Organization (WHO) presents his compliments
to States Parties to the International Health Regulations (2005) (IHR or Regulations) and has the
honour to inform them that, pursuant to articles 17, 50 and 53 of the Regulations, the following
IHR Review Committees, sharing the same composition, are being convened to meet on
27 July 2023:
– IHR Review Committee regarding Standing Recommendations for COVID-19; and
– IHR Review Committee regarding Standing Recommendations for mpox.
In this connection, and in accordance with article 51, paragraph 2 of the IHR, the
Director-General of the WHO has the honour to invite States Parties to designate two
representatives to attend a dedicated virtual session of the Committees taking place on
Thursday, 27 July 2023 from 17:30 to 18:30 CEST. During that session, participants will be
briefed by the Chair of the Committees on the outcome of their closed sessions, scheduled earlier
on the same day.
The representatives designated to attend should register in INDICO, by 24 July 2023, using
the following link: https://indico.un.org/e/IHRRCSR-virtualsession. Connection details will be
communicated ahead of the session to the email addresses of the representative(s) provided.
The Director-General of the World Health Organization takes this opportunity to renew to
States Parties to the International Health Regulations (2005) the assurance of his highest
consideration.
GENEVA, 20 July 2023
Saatja: <
[email protected]>
Saadetud: 21.07.2023 11:52
Teema: WHO: C.L.28.2023 (IHR Review Committee)
Dear States Parties of the International Health Regulations (2005),Please
find attached, in the six official languages, C.L.28.2023 regarding a
dedicated virtual session of the Committees under the International
Health Regulations (2005) on 27 July 2023. Best regards,Department of
Governing BodiesWorld Health Organization***DO NOT RESPOND TO THIS E-
MAIL. YOU WILL NOT RECEIVE A REPLY***